Author

N. Mora-Ayestarán

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#gene editing Open access Nov 2026

Transthyretin Amyloid Cardiomyopathy: Contemporary Pharmacological Management

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive infiltrative cardiomyopathy increasingly recognised as a cause of heart failure. Advances in the understanding of its pathophysiology have enabled the development of targeted therapies, making ATTR-CM a paradigm of precision medicine in cardiology. Current...

M. T. Basurte-Elorz, Gemma Lacuey-Lecumberri, N. Mora-Ayestarán · European Cardiology Review · 0 citations

Oct 2026

Adverse Remodeling and Fibrosis Predict Outcomes in Excessive Trabeculation of the Left Ventricle: A Multiparametric CMR Risk Score.

BACKGROUND Excessive trabeculation of the left ventricle (ETLV) is a heterogeneous and controversial phenotype that overlaps with both physiological remodeling and cardiomyopathy. OBJECTIVES This study sought to develop and validate a cardiac magnetic resonance (CMR)-based model to predict major adverse cardiovascula...

Guillem Casas, E. Ródenas-Alesina, Javier Limeres et al. · JACC Cardiovascular Imaging · 0 citations

Sep 2026

Arrhythmic Risk Stratification According to LGE Corridors and Genetics in Nonischemic Dilated Cardiomyopathy.

These findings support MVA multiparametric prediction over the traditional left ventricular ejection fraction ≤35% threshold and allow clinically meaningful arrhythmic risk classification in patients with nonischemic dilated cardiomyopathy.

Noemí Ramos-López, N. Mora-Ayestarán, Juan Pablo Ochoa et al. · Circulation · 0 citations